Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The application of nitric oxide for ocular hypertension treatment
Hope DCD, Vincent ML, Tan TMM
A licensed healthcare provider will review your health and medical history to determine if you qualify for GLP-1 treatment and discuss your options with you before prescribing medication
Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023
It also found patients taking the highest dose of the oral GLP-1 agonist, which is currently in development for type 2 diabetes and weight management treatment, lost an average of 7.6% of their body weight
If you develop new or worsening symptoms after starting GLP-1 probiotics, discontinue use and consult your healthcare provider
